Macrophage depletion impairs wound healing and increases left ventricular remodeling after myocardial injury in mice.

Macrophages have been suggested to be beneficial for myocardial wound healing. We investigated the role of macrophages in myocardial wound healing by inhibition of macrophage infiltration after myocardial injury. We used a murine cryoinjury model to induce left ventricular damage. Infiltrating macrophages were depleted during the 1st week after cryoinjury by serial intravenous injections of clodronate-containing liposomes. After injury, the presence of macrophages, which secreted high levels of transforming growth factor-beta and vascular endothelial growth factor-A, led to rapid removal of cell debris and replacement by granulation tissue containing inflammatory cells and blood vessels, followed by myofibroblast infiltration and collagen deposition. In macrophage-depleted hearts, nonresorbed cell debris was still observed 4 weeks after injury. Secretion of transforming growth factor-beta and vascular endothelial growth factor-A as well as neovascularization, myofibroblast infiltration, and collagen deposition decreased. Moreover, macrophage depletion resulted in a high mortality rate accompanied by increased left ventricular dilatation and wall thinning. In conclusion, infiltrating macrophage depletion markedly impairs wound healing and increases remodeling and mortality after myocardial injury, identifying the macrophage as a key player in myocardial wound healing. Based on these findings, we propose that increasing macrophage numbers early after myocardial infarction could be a clinically relevant option to promote myocardial wound healing and subsequently to reduce remodeling and heart failure.

[1]  S. Leibovich,et al.  Promotion of wound repair in mice by application of glucan. , 1980, Journal of the Reticuloendothelial Society.

[2]  M. Sporn,et al.  Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[3]  M. Sporn,et al.  Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. , 1987, Science.

[4]  D. C. Miller,et al.  Cardiac cryolesions as an experimental model of myocardial wound healing. , 1987, Annals of Surgery.

[5]  D. Wiseman,et al.  Macrophages, wound repair and angiogenesis. , 1988, Progress in clinical and biological research.

[6]  G. Roth,et al.  Promotion of wound repair in old mice by local injection of macrophages. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[7]  A. Desmoulière,et al.  Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.

[8]  S. Kawashima,et al.  Effects of late reperfusion on infarct expansion and infarct healing in conscious rats. , 1993, The American journal of pathology.

[9]  N. Van Rooijen,et al.  Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. , 1994, Journal of immunological methods.

[10]  V. Richard,et al.  Healing of myocardial infarcts in dogs. Effects of late reperfusion. , 1995, Circulation.

[11]  M. Daemen,et al.  Collagen remodeling after myocardial infarction in the rat heart. , 1995, The American journal of pathology.

[12]  K. Thomas.  Vascular Endothelial Growth Factor, a Potent and Selective Angiogenic Agent (*) , 1996, The Journal of Biological Chemistry.

[13]  Y. Takei,et al.  Liposome‐encapsulated dichloromethylene diphosphonate induces macrophage apoptosis in vivo and in vitro , 1996, Journal of leukocyte biology.

[14]  T. K. van den Berg,et al.  Apoptosis of macrophages induced by liposome-mediated intracellular delivery of clodronate and propamidine. , 1996, Journal of immunological methods.

[15]  L. Katwa,et al.  Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. , 1997, Journal of molecular and cellular cardiology.

[16]  R. Lang,et al.  Macrophages induce apoptosis in normal cells in vivo. , 1997, Development.

[17]  S. Kaul,et al.  Tenascin-C is expressed in macrophage-rich human coronary atherosclerotic plaque. , 1999, Circulation.

[18]  F. Galeazzi,et al.  Inflammation-induced impairment of enteric nerve function in nematode-infected mice is macrophage dependent. , 2000, American journal of physiology. Gastrointestinal and liver physiology.

[19]  F. C. Lucibello,et al.  Endothelial-like cells derived from human CD14 positive monocytes. , 2000, Differentiation; research in biological diversity.

[20]  S. Shapiro,et al.  Contribution of Monocytes/Macrophages to Compensatory Neovascularization: The Drilling of Metalloelastase-Positive Tunnels in Ischemic Myocardium , 2000, Circulation research.

[21]  W. Daniel,et al.  Monocytes coexpress endothelial and macrophagocytic lineage markers and form cord-like structures in Matrigel under angiogenic conditions. , 2001, Cardiovascular research.

[22]  I. Fishbein,et al.  Macrophage Depletion by Clodronate-Containing Liposomes Reduces Neointimal Formation After Balloon Injury in Rats and Rabbits , 2002, Circulation.

[23]  P. Carmeliet,et al.  VEGFR-1–Selective VEGF Homologue PlGF Is Arteriogenic: Evidence for a Monocyte-Mediated Mechanism , 2003, Circulation research.

[24]  L. Katwa.  Cardiac myofibroblasts isolated from the site of myocardial infarction express endothelin de novo. , 2003, American Journal of Physiology. Heart and Circulatory Physiology.

[25]  Christie M. Orschell,et al.  Peripheral Blood “Endothelial Progenitor Cells” Are Derived From Monocyte/Macrophages and Secrete Angiogenic Growth Factors , 2003, Circulation.

[26]  A. Takeshita,et al.  Anti-Monocyte Chemoattractant Protein-1 Gene Therapy Attenuates Left Ventricular Remodeling and Failure After Experimental Myocardial Infarction , 2002, Circulation.

[27]  M. Arai,et al.  Acceleration of the Healing Process and Myocardial Regeneration May Be Important as a Mechanism of Improvement of Cardiac Function and Remodeling by Postinfarction Granulocyte Colony–Stimulating Factor Treatment , 2004, Circulation.

[28]  R. Coleman,et al.  Therapeutic angiogenesis in chronically ischemic porcine myocardium: comparative effects of bFGF and VEGF. , 2004, The Annals of thoracic surgery.

[29]  M. Entman,et al.  Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. , 2004, The American journal of pathology.

[30]  N. Van Rooijen,et al.  Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response1 , 2004, The Journal of Immunology.

[31]  S. Dimmeler,et al.  Endothelial Progenitor Cells: Characterization and Role in Vascular Biology , 2004, Circulation research.

[32]  M. Hiroe,et al.  Tenascin-C regulates recruitment of myofibroblasts during tissue repair after myocardial injury. , 2005, The American journal of pathology.

[33]  D. J. Veldhuisen,et al.  Impaired renal function is not only related to decreased cardiac output but also to increased venous pressure in patients with cardiac dysfunction , 2006 .

[34]  M. Harmsen,et al.  The enzymatic degradation of scaffolds and their replacement by vascularized extracellular matrix in the murine myocardium. , 2006, Biomaterials.

[35]  J. Leor,et al.  Ex Vivo Activated Human Macrophages Improve Healing, Remodeling, and Function of the Infarcted Heart , 2006, Circulation.

[36]  K. Shimamoto,et al.  Macrophage colony-stimulating factor treatment after myocardial infarction attenuates left ventricular dysfunction by accelerating infarct repair. , 2006, Journal of the American College of Cardiology.

[37]  M. Harmsen,et al.  Increased inflammatory response and neovascularization in reperfused vs. non-reperfused murine myocardial infarction. , 2006, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.